-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Neurocrine Biosciences Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2019 to Q3 2024.
- Neurocrine Biosciences Inc Costs and Expenses for the quarter ending September 30, 2024 was $438M, a 22.6% increase year-over-year.
- Neurocrine Biosciences Inc Costs and Expenses for the twelve months ending September 30, 2024 was $1.66B, a 5.32% increase year-over-year.
- Neurocrine Biosciences Inc annual Costs and Expenses for 2023 was $1.64B, a 32% increase from 2022.
- Neurocrine Biosciences Inc annual Costs and Expenses for 2022 was $1.24B, a 20.2% increase from 2021.
- Neurocrine Biosciences Inc annual Costs and Expenses for 2021 was $1.03B, a 16.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)